Former President Joe Biden has been diagnosed with metastatic prostate cancer at age 82. The former president's office said he has an "aggressive form" of the cancer, which has spread to his bones.

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found.

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form.

ORLANDO, Fla. (Ivanhoe Newswire) - Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced ...

Experts recommend regular screening to increase the chance of detecting prostate cancer early, when it is most treatable. (Dreamstime/TCA) Prostate cancer is one of the most common cancers in the ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for Getty Prostate cancer is one of the most common types of cancer in males. It starts in the prostate, a ...

ORLANDO, Fla. (Ivanhoe Newswire) --- Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has ...

Former President Joe Biden has seen an outpouring of support following an announcement that he has prostate cancer. The 82-year-old shared his diagnosis on Sunday calling it aggressive and adding that ...

If you're facing a prostate cancer diagnosis, this guide to best dietary practices will help simplify your shopping list Getty What you eat can affect your prostate health, for better or worse.

QUESTION: I'm a guy in my late 40s and trying to pay more attention to my health. But I'm confused about whether I should be screened for prostate cancer. Can you help? ANSWER: The importance of all ...

Study links higher expression of the gene PROX1 to aggressive change in prostate tumor cells; FDA-approved class of drugs can disable PROX1 ANN ARBOR, Michigan — Researchers at the University of ...